Latest filing published 16 May 2022 for MITHRA PHARMACEUTICALS, €2.5M.
Fornieri Francesco is a declared insider of Mithra Pharmaceuticals, with filings sourced from FSMA. Between 27 May 2021 and 15 May 2022, the trades on record add up to 41 filings.
Every open-market trade on record is a sale: 36 sales worth €15.2M. So far in 2022, the count stands at no purchases and 11 sales.
The latest filing, published on 16 May 2022, reports a transaction of €2.5M in Mithra Pharmaceuticals. Filings reach the FSMA feed a median of 7 days after the trade. Under the Market Abuse Regulation, managers have three business days to notify their trades. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by FSMA. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 41 declarations